Patrick S. Moore, MD, MPH
Director, Cancer Virology Program
American Cancer Society Research Professor
Professor, Department of Microbiology and Medical Genetics
Office Phone: 412-623-7721, -7718
Lab Phone: 412-623-7733
Hillman Cancer Research Pavilion
5117 Centre Ave.
Pittsburgh, PA 15213
Director, Molecular Virology Program, UPCI
Professor, Molecular Genetics and Biochemistry
|1998-2002||Professor of Public Health
Division of Epidemiology
Columbia University, New York, NY
|1995-1998||Associate Professor of Public Health Division of Epidemiology Columbia University, New York, NY|
|1994-1995||Assistant Professor of Public Health Division of Epidemiology Columbia University, New York, NY|
New York City Department of Health, New York, NY
|1991-1993||Chief, Epidemiology Section:
Arboviral Diseases Branch, Centers for Disease Control,
Fort Collins, CO
|1989-1991||MPH; University of California, Berkley
AIDS Prevention Studies (CAPS) Scholar
|1987-1989||Epidemic Intelligence Service (EIS) Officer,
Meningitis and Special Pathogens Branch,
Centers for Disease Control and Prevention (CDC)
|1986-1986||Research Physician: Onchocerciasis Research Project
LAC, Liberia (Case Western Reserve University)
|1985-1985||Medical Officer: Bawku Presbyterian Hospital, Ghana|
Biosketch: Patrick S. Moore, MD, MPH is an American Cancer Society (ACS) and Distinguished Professor in the Department of Microbiology and Molecular Genetics, University of Pittsburgh. He is Director of the Cancer Virology Program for the University of Pittsburgh Cancer Institute and holds the Pittsburgh Foundation Chair in Innovative Cancer Research. Dr. Moore is recognized for his role, together with Dr. Yuan Chang - also an ACS Professor, in discovering and characterizing Kaposi sarcoma herpesvirus (KSHV or HHV8) and Merkel cell polyomavirus (MCV), the two most recently recognized human tumor viruses. Dr. Moore and Chang’s laboratory maintain an active focus on basic and translational research for both KSHV and MCV. Dr. Moore has received the General Motors Cancer Research Foundation Mott Award, the Robert Koch Prize, the Meyenburg Cancer Research Prize, CDC-Langmuir Award as well as other awards, is an elected member of the US National Academy of Science as well as other professional honor societies and holds 21 patents. He is a Thomson Reuter ISI Highly Cited Researcher with over 20,000 scientific citations. He graduated from Westminster College in Salt Lake City, UT and received medical and graduate degrees from the University of Utah, Stanford University and University California, Berkeley and trained at the Centers for Disease Control as an Epidemic Intelligence Service (EIS) officer. In addition to his work on tumor viruses, he has expertise in refugee health and management and in control of meningococcal meningitis epidemics.
- Feng H, Shuda M, Chang Y, Moore PS. Clonal Integration of a Polyomavirus in Merkel Cell Carcinoma. Science 2008:319; 1096-1100.
- Shuda M, Feng H, Kwun H, Rosen ST, Gjoerup O, Moore PS, Chang Y. T-antigen mutations are a tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci, USA. 2008;105(42):16272-7. PMCID: 2551627.
- Shuda, M., R. Arora, H. J. Kwun, H. Feng, R. Sarid, M. T. Fernandez-Figueras, Y. Tolstov, O. Gjoerup, M. M. Mansukhani, S. H. Swerdlow, P. M. Chaudhary, J. M. Kirkwood, M. A. Nalesnik, J. A. Kant, L. M. Weiss, P. S. Moore, and Y. Chang. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009;125:1243-9.
- Tolstov Y, Pastrana D, Feng H, Becker J, Jenkins F, Moschos S, Chang Y, Buck C, Moore PS. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays Int J Cancer 2009;125:1250-1256.
- Busam K, Jungbluth AA, Rekhtman N, Coit D, Pulitzer M, Bini JM, Arora R, Hanson NC, Tassello JA, Frosina D, Moore P, Chang Y. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.2009 Am J Surg Path 2009;33(9):1378-85.
- Pastrana, DV, Tolstov YL, Becker JC, Moore PS, Chang Y, and Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009 In Press
- Kwun HJ, Guastafierro A, Shuda M, Meinke G, Bohm A, Moore PS, and Chang Y. The minimum replication origin of Merkel cell polyomavirus has a unique large T antigen loading architecture and requires small T antigen expression for optimal replication. J Virol 2009 In Press.
- Li Z, Kim SW, Lin Y, Moore PS, Chang Y, John B. Characterization of viral and human RNAs smaller than canonical microRNAs. J Virol 2009 83(24):12751-12578.
- Kwun HJ, Guastafierro A, Shuda M, Meinke G, Bohm A, Moore PS, and Chang Y. The minimum replication origin of Merkel cell polyomavirus has a unique large T antigen loading architecture and requires small T antigen expression for optimal replication. J Virol, 2009 Dec;83(23):12118-28.
- Pastrana, DV, Tolstov YL, Becker JC, Moore PS, Chang Y, and Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog, 2009. Sept;5(9):e1000578.
- Moschos S, Chang Y, and Moore PS. Merkel Cell Polyomavirus: The Seventh Human Cancer Virus? The Melanoma Letter, 2009 Summer;27(2).
- Kim S, Li Z, Moore PS, Monaghan A, Chang Y, Nichols M, John B. A sensitive nonradioactive northern blot method to detect small RNAs. Nuc Acids Research, 2010 Apr 1;38(7):e98. Epub 2010 Jan 15.